CILOXAN Eye drops, solution Ref.[6736] Active ingredients: Ciprofloxacin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Novartis Pharmaceuticals UK Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

Product name and form

CILOXAN 0.3% w/v eye drops, solution.

Pharmaceutical Form

Eye drops, solution.

A clear and colourless to pale yellow solution.

Qualitative and quantitative composition

Ciprofloxacin 0.3% w/v (as hydrochloride).

Excipients with known effect: One ml of solution contains 0.06mg of benzalkonium chloride.

For a full list of excipients, see Section 6.1.

Active Ingredient Description
Ciprofloxacin

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

List of Excipients

Benzalkonium chloride
Disodium edetate
Mannitol
Glacial acetic acid
Sodium acetate
Hydrochloric acid/sodium hydroxide
Purified water

Pack sizes and marketing

5 ml Drop-Tainer LDPE bottle and plug with a polystyrene or polypropylene cap.

Marketing authorization holder

Novartis Pharmaceuticals UK Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

Marketing authorization dates and numbers

PL 00101/0994

23 November 1993 / 17 February 2004

Drugs

Drug Countries
CILOXAN Austria, Australia, Brazil, Canada, Cyprus, Estonia, France, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.